RaySearch Laboratories AB's total inventories for the quarter that ended in Mar. 2026 was kr49 Mil. RaySearch Laboratories AB's average total inventories from the quarter that ended in Dec. 2025 to the quarter that ended in Mar. 2026 was kr36 Mil.
In Ben Graham's calculation of Net-Net Working Capital, inventory is only considered worth half of its book value. RaySearch Laboratories AB's Net-Net Working Capital per share for the quarter that ended in Mar. 2026 was kr-10.92.
Days Inventory indicates the number of days of goods in sales that a company has in the inventory.
RaySearch Laboratories AB's Days Inventory for the
three
months ended in Mar. 2026 was 137.85.
Inventory Turnover measures how fast the company turns over its inventory within a year.
RaySearch Laboratories AB's Inventory Turnover for the quarter that ended in Mar. 2026 was 0.66.
Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RaySearch Laboratories AB's Inventory-to-Revenue for the quarter that ended in Mar. 2026 was 0.12.
RaySearch Laboratories AB (LTS:0GRZ) Total Inventories Explanation
Inventory control is an important part of business operation. If a company does not have enough inventory, it may not be able to meet customers' required delivery time. If it has too much inventory, the cost of holding the inventory can be high.
1. In Ben Graham's calculation of Net-Net Working Capital (NNWC), inventory is only considered worth half of its book value.
RaySearch Laboratories AB's Net-Net Working Capital Per Share for the quarter that ended in Mar. 2026 is
4. Inventory-to-Revenue determines the ability of a company to manage their inventory levels. It measures the percentage of Inventories the company currently has on hand to support the current amount of Revenue.
RaySearch Laboratories AB's Inventory to Revenue for the quarter that ended in Mar. 2026 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Be Aware
Manufacturers with durable competitive advantages have the advantage that the products they sell do not change, and therefore will never become obsolete. Buffett likes this advantage.
When identifying manufacturers with durable competitive advantage, look for inventory and net earnings that rise correspondingly. This indicates that the company is finding profitable ways to increase sales which called for an increase in inventory.
Manufacturers with inventories that spike up and down are indicative of competitive industries subject to boom and bust.
RaySearch Laboratories AB Total Inventories Related Terms
RaySearch Laboratories AB Total Inventories Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
RaySearch Laboratories AB Total Inventories Calculation
Total Inventories includes the raw materials, work-in-process goods and completely finished goods of a company. It is a portion of a company's current assets.
RaySearch Laboratories AB (LTS:0GRZ) has a Total Inventories of kr49 Mil as of Mar. 2026. The total amount of inventory as recorded on a company's balance sheet. View historical data for RaySearch Laboratories AB and its competitors.
Is RaySearch Laboratories AB's Total Inventories too high?
RaySearch Laboratories AB's current Total Inventories is kr49 Mil. Overall, RaySearch Laboratories AB has a GF Score™ of 83/100 and is considered Modestly Overvalued, reflecting its overall financial health beyond just this single metric.
How does RaySearch Laboratories AB's Total Inventories compare to VEEV and BTSG?
RaySearch Laboratories AB's Total Inventories of kr49 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Inventories for a Healthcare Providers & Services company?
A good Total Inventories depends on the Healthcare Providers & Services industry context. However, Total Inventories should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Inventories mean?
A high Total Inventories can signal that a stock is expensive relative to its fundamentals. The total amount of inventory as recorded on a company's balance sheet. View historical data for RaySearch Laboratories AB and its competitors. RaySearch Laboratories AB's current Total Inventories is kr49 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RaySearch Laboratories AB stock overvalued right now?
Based on GuruFocus' analysis, RaySearch Laboratories AB (LTS:0GRZ) is currently considered Modestly Overvalued. The stock's GF Value™ is kr188.99, compared to a current price of kr232.20 — trading 22.9% above its estimated fair value. The current Total Inventories is kr49 Mil. RaySearch Laboratories AB's overall GF Score™ is 83/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Inventories calculated?
Total Inventories is calculated from a company's financial statements. For RaySearch Laboratories AB (LTS:0GRZ), the current Total Inventories is kr49 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is RaySearch Laboratories AB (LTS:0GRZ) Overvalued in 2026?
Based on GuruFocus' analysis, RaySearch Laboratories AB stock appears to be overvalued.
The current stock price of kr232.20 is trading 22.9% above its estimated GF Value™ of kr188.99.
GuruFocus considers RaySearch Laboratories AB to be Modestly Overvalued.
Key valuation signals for LTS:0GRZ:
Total Inventories: kr49 Mil
GF Value™: kr188.99 vs. price of kr232.20 (22.9% above fair value)
No single metric tells the full story. See the LTS:0GRZ stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops software solutions for improved cancer treatment. The company develops and markets the RayStation treatment planning system and RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of the Americas, Asia-Pacific & Middle East, Europe, and the rest of world.
83GF Score
Get the complete analysis for LTS:0GRZ
Total Inventories is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LTS:0GRZ has been successfully added to your 
